Is Beaten-Down Phibro Animal Health Stock a Buy Following an Insider Purchase of 10,000 Shares?
E. Thomas Corcoran, Director of Phibro Animal Health Corporation (NASDAQ:PAHC), reported the acquisition of 10,000 shares of Common Stock at a weighted average price of $31.77 per share on May 29, 2026, according to a SEC Form 4 filing.
Transaction summary
|
Metric |
Value |
|---|---|
|
Shares traded |
10,000 |
|
Transaction value |
~$318,000 |
|
Post-transaction shares (direct) |
41,459 |
|
Post-transaction value (direct ownership) |
~$1.27 million |
Transaction value based on SEC Form 4 weighted average purchase price ($31.77); post-transaction value based on May 29, 2026 transaction price ($31.77).
Key questions
-
How does this transaction compare to Corcoran’s prior trading activity?
The 10,000-share purchase is the largest of three open-market acquisitions made by Corcoran since September 2024, exceeding his prior buys of 5,000 shares each. -
What is the current capacity for further acquisitions?
Following this transaction, Corcoran’s holdings increased by 31.79% to 41,459 shares, providing an enlarged capacity for future activity relative to his prior baseline. -
Was this purchase timed around material changes in market price?
The acquisition occurred with shares priced at $31.77, closely aligning with the May 29, 2026, market open of $31.76 and closing at $30.66, indicating the purchase was not timed to a dramatic price move. -
Does the transaction reflect a change in indirect or derivative exposure?
No indirect or derivative transactions were disclosed; Corcoran’s entire exposure remains in directly held Class A Common Stock.
Company overview
|
Metric |
Value |
|---|---|
|
Revenue (TTM) |
$1.50 billion |
|
Net income (TTM) |
$95.23 million |
|
Dividend yield |
1..5% |
|
1-year price change |
-17.45% |
* 1-year price change calculated using June 12, 2026, as the reference date.
Company snapshot
-
Phibro Animal Health Corporation offers a portfolio of animal health products, mineral nutrition solutions, and specialty performance products, with revenue primarily generated from sales to the livestock industry.
-
The company operates a vertically integrated business model, developing, manufacturing, and marketing products that address animal health, disease prevention, and nutritional needs for food-producing animals.
-
Primary customers include integrated poultry, swine, and cattle producers, as well as commercial feed manufacturers, wholesalers, and distributors across the United States and international markets.
Phibro Animal Health Corporation is a leading provider of animal health and mineral nutrition products, serving a global customer base with a focus on food animal production. The company leverages a diversified product portfolio and established distribution channels to maintain a competitive position in the animal health industry.
